Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.500 | None | 0.921 | 4 | 0 | 1996 | 2019 | ||||||||
|
dopamine receptor D5 | 0.603 | 0.423 | 1.3E-16 |
|
disease | 0.500 | None | 0.900 | 2 | 0 | 2000 | 2016 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.873 | 1 | 0 | 1996 | 2019 | ||||||||
|
steroid sulfatase | 0.431 | 0.846 | 0.81 |
|
disease | 0.460 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
glutamate metabotropic receptor 5 | 0.525 | 0.846 | 1.00 |
|
disease | 0.450 | None | 1.000 | 2 | 1 | 2010 | 2015 | ||||||||
|
FYVE, RhoGEF and PH domain containing 1 | 0.573 | 0.731 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
arsenite methyltransferase | 0.638 | 0.538 | 8.0E-11 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2013 | 2015 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.950 | 4 | 0 | 1995 | 2019 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
capicua transcriptional repressor | 0.523 | 0.692 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adhesion G protein-coupled receptor L3 | 0.729 | 0.385 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
mediator complex subunit 13 | 0.711 | 0.538 | 1.00 |
|
disease | 0.400 | moderate | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
tryptophan hydroxylase 2 | 0.546 | 0.654 | 2.5E-07 |
|
disease | 0.400 | None | 0.933 | 0 | 0 | 2005 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
glutamate metabotropic receptor 7 | 0.628 | 0.538 | 1.00 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
GIT ArfGAP 1 | 0.647 | 0.538 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2011 | 2018 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2010 | 2016 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
glutamate metabotropic receptor 8 | 0.636 | 0.577 | 4.5E-07 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2011 | 2015 | ||||||||
|
protein tyrosine phosphatase receptor type D | 0.584 | 0.731 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
calcyon neuron specific vesicular protein | 0.821 | 0.192 | 3.9E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
cholinergic receptor nicotinic beta 2 subunit | 0.617 | 0.308 | 7.3E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
zinc finger protein 292 | 0.695 | 0.423 | 1.00 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
glutamate metabotropic receptor 1 | 0.528 | 0.808 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 |